| Cat. No. |
Product Name |
Effect
|
Purity |
Rare Diseases
|
| HY-P10408 |
Candidalysin |
Activator |
99.81% |
Unkown |
| HY-N0231 |
Bavachalcone |
|
99.90% |
Unkown |
| HY-N2119 |
Sciadopitysin |
Inhibitor |
99.0% |
Unkown |
| HY-N6837 |
Fructo-oligosaccharide DP7/GF6 |
|
99.94% |
Unkown |
| HY-P10927 |
BRP |
|
95.15% |
Unkown |
| HY-N5048 |
Galloylpaeoniflorin |
Inhibitor |
98.30% |
Unkown |
| HY-N0805A |
Alisol B |
|
99.57% |
Unkown |
| HY-165126 |
Schizophyllan |
|
/ |
Unkown |
| HY-A0299 |
H-Gly-Pro-Hyp-OH |
Inhibitor |
99.48% |
Unkown |
| HY-P10506 |
CMX-8933 |
Activator |
99.77% |
Unkown |
| HY-107621 |
U0124 |
|
98.0% |
Unkown |
| HY-169021 |
JNK-1-IN-3 |
Inhibitor |
98.44% |
Unkown |
| HY-59201A |
A-582941 dihydrochloride |
|
99.78% |
Unkown |
| HY-182757 |
Y1693 |
Inhibitor |
99.91% |
Unkown |
| HY-N6836 |
Fructo-oligosaccharide DP8/GF7 |
|
99.76% |
Unkown |
| HY-124277 |
ADM 12 |
Antagonist |
98.86% |
Unkown |
| HY-P10927A |
BRP TFA |
|
/ |
Unkown |
| HY-B1052S |
Lofexidine-d4 hydrochloride |
Agonist |
/ |
Unkown |
| HY-100839 |
(RS)-(Tetrazol-5-yl)glycine |
Agonist |
96.53% |
Unkown |
| HY-106584 |
Mosapramine |
Antagonist |
98.58% |
Unkown |
| HY-114753 |
Neboglamine |
Modulator |
/ |
Unkown |
| HY-168895 |
c-Fos-IN-1 |
|
97.24% |
Unkown |
| HY-N6835 |
Fructo-oligosaccharide DP9/GF8 |
|
99.83% |
Unkown |
| HY-P10405A |
TAT-D1 peptide acetate |
Inhibitor |
/ |
Unkown |
| HY-RS05032 |
FOS Human Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-RS16815 |
Fos Mouse Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |
| HY-106153B |
E-5842 citrate |
Ligand |
/ |
Unkown |
| HY-107614G |
1-Oleoyl lysophosphatidic acid sodium (GMP) |
Activator |
/ |
Unkown |
| HY-113443 |
12(S)-HPETE |
Activator |
/ |
Unkown |
| HY-113756B |
rel-Latanoprost acid |
Agonist |
/ |
Unkown |
| HY-116640 |
Amorphigenin |
Inhibitor |
/ |
Unkown |
| HY-120306 |
HHL-6 |
Inhibitor |
/ |
Unkown |
| HY-12270S |
T-5224-d8 |
|
/ |
Unkown |
| HY-131721 |
14,15-EET-SI |
Activator |
/ |
Unkown |
| HY-15026 |
ATB 429 |
|
/ |
Unkown |
| HY-168482 |
NF-κB/MAPK-IN-2 |
Inhibitor |
/ |
Unkown |
| HY-168895A |
(E,E)-c-Fos-IN-1 |
|
/ |
Unkown |
| HY-169451 |
Cannabidiolic acid methyl ester |
Modulator |
/ |
Unkown |
| HY-175007 |
RIPK1-IN-32 |
Inhibitor |
/ |
Unkown |
| HY-176019 |
Methylcarbamyl PAF C-8 |
|
/ |
Unkown |
| HY-179216 |
KTT-1 |
Inhibitor |
/ |
Unkown |
| HY-179684 |
PCC0105005 |
|
/ |
Unkown |
| HY-182504 |
NRA-0562 |
|
/ |
Unkown |
| HY-59201 |
A-582941 |
|
/ |
Unkown |
| HY-A0116S1 |
Trandolaprilate-d6 |
|
/ |
Unkown |
| HY-B1052S1 |
Lofexidine-d4 |
Agonist |
/ |
Unkown |
| HY-E70684 |
CDK5/p25NCK Recombinant Human Active Protein Kinase |
|
/ |
Unkown |
| HY-E70685 |
CDK5/p35NCK Recombinant Human Active Protein Kinase |
|
/ |
Unkown |
| HY-N11775 |
Eudebeiolide B |
|
/ |
Unkown |
| HY-N1326 |
Santamarine |
|
98.85% |
Unkown |
| HY-N18209 |
4-Hydroxy-3-butylphthalide |
|
/ |
Unkown |
| HY-N3071 |
Picrasidine I |
|
/ |
Unkown |
| HY-N6834 |
Fructo-oligosaccharide DP10/GF9 |
|
98.0% |
Unkown |
| HY-P11617 |
CLP-d2 |
Inhibitor |
/ |
Unkown |
| HY-174682 |
Human FOS mRNA |
|
/ |
Unkown |
| HY-B1606 |
Chlorothymol |
|
99.70% |
Unkown |
| HY-N7008 |
Fructo-oligosaccharide DP11/GF10 |
|
/ |
Unkown |
| HY-N7009 |
Fructo-oligosaccharide DP12/GF11 |
|
98.0% |
Unkown |
| HY-P10405 |
TAT-D1 peptide |
Antagonist |
/ |
Unkown |
| HY-RS23255 |
Fos Rat Pre-designed siRNA Set A |
Pre-designed Set |
/ |
Unkown |